OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
300107$7.4155

Hebei Jianxin Chemical Co Ltd

Specialty ChemicalsVerified

Hebei Jianxin Chemical Co Ltd operates with a market capitalization of 4.17 billion CNY and a price-to-book ratio of 2.84, indicating a premium valuation relative to its book value. The company's liquidity position is characterized by a current ratio of 4.15, suggesting strong short-term liquidity, but its free cash flow is negative at -133.92 million CNY, indicating that capital expenditures are outpacing operating cash flow. The company's debt-to-equity ratio is low at 0.02, reflecting a conservative capital structure. Profitability metrics show a challenging operating environment for the company. The return on equity is -1.89%, and the return on assets is -1.71%, both significantly below the industry median for specialty chemicals, which typically shows positive returns. The company reported a net loss of 27.74 million CNY, with an operating loss of 29.66 million CNY, indicating a lack of operational profitability. Geographically, the company's revenue is concentrated in China, with no disclosed international operations. Segment-wise, the company operates as a single business unit, with no material diversification across product lines or geographic regions. This concentration increases exposure to domestic economic and regulatory shifts. The company's growth trajectory is mixed. While revenue for the latest period was 465.44 million CNY, the operating and net losses suggest a contraction in profitability. The capital expenditure of -167.77 million CNY indicates significant investment in infrastructure or expansion, but the negative free cash flow suggests these investments are not yet generating returns. The outlook for the next fiscal year is uncertain, with no clear direction provided in the available data. Risk factors include the company's negative net cash position after subtracting total debt, which could limit its ability to fund operations or respond to market pressures. The dilution risk is currently low, with no near-term pressure from share issuance or convertible instruments. However, the company's negative operating cash flow and net loss raise concerns about its ability to sustain operations without external financing. Recent events include the filing of financial results showing a net loss and a significant operating loss. No recent earnings call transcripts or major regulatory filings have been disclosed in the available data.

30-day price · 300107+0.70 (+10.4%)
Low$6.69High$7.83Close$7.41As of20 May, 00:00 UTC
Profile
CompanyHebei Jianxin Chemical Co Ltd
Ticker300107.SZ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. Hebei Jianxin Chemical Co Ltd is a Chinese specialty chemicals company that produces and sells chemical products, primarily serving industrial and manufacturing sectors.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry with a confidence level of 0.92.

Hebei Jianxin Chemical Co Ltd operates with a market capitalization of 4.17 billion CNY and a price-to-book ratio of 2.84, indicating a premium valuation relative to its book value. The company's liquidity position is characterized by a current ratio of 4.15, suggesting strong short-term liquidity, but its free cash flow is negative at -133.92 million CNY, indicating that capital expenditures are outpacing operating cash flow. The company's debt-to-equity ratio is low at 0.02, reflecting a conservative capital structure. Profitability metrics show a challenging operating environment for the company. The return on equity is -1.89%, and the return on assets is -1.71%, both significantly below the industry median for specialty chemicals, which typically shows positive returns. The company reported a net loss of 27.74 million CNY, with an operating loss of 29.66 million CNY, indicating a lack of operational profitability. Geographically, the company's revenue is concentrated in China, with no disclosed international operations. Segment-wise, the company operates as a single business unit, with no material diversification across product lines or geographic regions. This concentration increases exposure to domestic economic and regulatory shifts. The company's growth trajectory is mixed. While revenue for the latest period was 465.44 million CNY, the operating and net losses suggest a contraction in profitability. The capital expenditure of -167.77 million CNY indicates significant investment in infrastructure or expansion, but the negative free cash flow suggests these investments are not yet generating returns. The outlook for the next fiscal year is uncertain, with no clear direction provided in the available data. Risk factors include the company's negative net cash position after subtracting total debt, which could limit its ability to fund operations or respond to market pressures. The dilution risk is currently low, with no near-term pressure from share issuance or convertible instruments. However, the company's negative operating cash flow and net loss raise concerns about its ability to sustain operations without external financing. Recent events include the filing of financial results showing a net loss and a significant operating loss. No recent earnings call transcripts or major regulatory filings have been disclosed in the available data.
Key takeaways
  • The company is trading at a premium to book value but is unprofitable, with negative returns on equity and assets.
  • Liquidity is strong in the short term, but free cash flow is negative, indicating operational inefficiencies.
  • The company's operations are concentrated in China, with no material international diversification.
  • Capital expenditures are high, but the negative free cash flow suggests these investments are not yet generating returns.
  • The company's negative net cash position and operating losses raise concerns about its financial sustainability.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$465.4M
Gross profit$28.2M
Operating income-$29.7M
Net income-$27.7M
R&D
SG&A
D&A
SBC
Operating cash flow$52.3M
CapEx-$167.8M
Free cash flow-$133.9M
Total assets$1.62B
Total liabilities$147.9M
Total equity$1.47B
Cash & equivalents
Long-term debt$33.5M
Valuation
Market price$7.41
Market cap$4.17B
Enterprise value$4.20B
P/E
Reported non-GAAP P/E
EV/Revenue9.0
EV/Op income
EV/OCF80.4
P/B2.8
P/Tangible book2.8
Tangible book$1.47B
Net cash-$33.5M
Current ratio4.2
Debt/Equity0.0
ROA-1.7%
ROE-1.9%
Cash conversion-1.9%
CapEx/Revenue-36.0%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric300107Activity
Op margin-6.4%0.4% medp25 -8.0% · p75 16.0%below median
Net margin-6.0%2.3% medp25 -11.6% · p75 11.8%below median
Gross margin6.1%20.8% medp25 14.9% · p75 24.0%bottom quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-36.0%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity2.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Source: analysis-pipeline (hybrid)Generated: 2026-05-21 01:28 UTCJob: 1a25a302